Conservative Versus Liberal Red Cell Transfusion in Myocardial Infarction Trial: The CRIT Pilot
NCT00126334 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 45
Last updated 2011-07-21
Summary
The purpose of this trial is to determine whether a conservative or a liberal blood transfusion strategy is better for patients with a heart attack and a low blood count.
Conditions
Interventions
- PROCEDURE
-
Packed Red Blood Cell Transfusion
transfusion of 1 unit of PRBCs
Sponsors & Collaborators
-
US Department of Veterans Affairs
collaborator FED -
Medstar Health Research Institute
lead OTHER
Principal Investigators
-
Howard A Cooper, M.D. · Medstar Health Research Institute
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-04-30
- Primary Completion
- 2010-12-31
- Completion
- 2011-01-31
Countries
- United States
Study Locations
More Related Trials
-
RBC Transfusion in Severe Anemia With Lactic Acidosis
NCT01586923 ·Status: COMPLETED ·Phase: PHASE3
-
T2* in Transfusion Dependant Anemia, MI, LVF, Normal Patients
NCT00520559 ·Status: COMPLETED
-
The Impact of Red Packed Cells Transfusion on the Main Biological Markers to Determine the Etiology of Anemias
NCT01409967 ·Status: COMPLETED
-
A Study to Observe the Causes and Treatment of Anemia in Critically Ill Children
NCT00211055 ·Status: COMPLETED
-
Long-term Follow-up of Subjects With Transfusion-Dependent β-Thalassemia (TDT) Treated With Ex Vivo Gene Therapy
NCT02633943 ·Status: ACTIVE_NOT_RECRUITING
-
Donor Iron Deficiency Study - Red Blood Cells From Iron-deficient Donors: Recovery and Storage Quality
NCT02889133 ·Status: COMPLETED ·Phase: NA
-
Impact of Preoperative Treatment of Anemia and Iron Deficiency in Cardiac Surgery on Outcome.
NCT02031289 ·Status: COMPLETED ·Phase: PHASE4
-
PICU Transfusion Study: Harmful Effects of Red Blood Cell Transfusions
NCT02087553 ·Status: COMPLETED
-
Intravenous Iron in Patients With Systolic Heart Failure and Iron Deficiency to Improve Morbidity & Mortality
NCT03036462 ·Status: COMPLETED ·Phase: PHASE4
-
The Israeli Trigger for Blood Transfusions in the ICU
NCT00413816 ·Status: UNKNOWN
-
A Trial to Assess the Effect of Transfusion Strategies on Fatigability Levels After Hospital Discharge
NCT04920045 ·Status: TERMINATED ·Phase: NA
-
Safety and Tolerability of a Single Dose of FCM vs. Standard of Care in Treating Iron Deficiency Anemia
NCT00704353 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in the Treatment of Anemia Secondary to Heavy Uterine Bleeding
NCT00395993 ·Status: COMPLETED ·Phase: PHASE3
-
Iron Replacement in Blood Donors
NCT00327067 ·Status: COMPLETED
-
Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Iron Dextran in Treating Iron Deficiency Anemia
NCT00704028 ·Status: COMPLETED ·Phase: PHASE3
-
Red Blood Cell - IMProving trAnsfusions for Chronically Transfused Recipients
NCT05255445 ·Status: COMPLETED
-
Induction of Stable Chimerism for Sickle Cell Anemia
NCT00029393 ·Status: COMPLETED ·Phase: PHASE2
-
Short-Term Effects & Safety of an Accelerated Intravenous Iron Regimen in Patients With Heart Failure
NCT01925703 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Contrast Media on Erythrocytes in Healthy Volunteers
NCT00285506 ·Status: COMPLETED
-
RH Genotype Matched RBC Transfusions
NCT04156893 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
The Purpose of the Study is to Examine Whether Iron Deficiency Anemia is Associated With Increased Production of Thrombin and Whether Correction of Anemia by Providing Iron Intravenously Causes a Significant Reduction in Production of Thrombin.
NCT02129907 ·Status: COMPLETED
-
Trial To Evaluate the Efficacy of Intravenous Iron in Older Adults With Unexplained Anemia
NCT01309659 ·Status: TERMINATED ·Phase: PHASE2
-
Study of Deferasirox for Treatment of Transfusional Iron Overload in Myelodysplastic Patients
NCT00110266 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation the Safety and Efficacy of KL003 Cell Injection in the Treatment of Transfusion-dependent β-thalassemia.
NCT05860595 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Observational Study on the Use of IV (Intravenous) Iron Therapy Among Subjects With Iron Deficiency Anemia
NCT01984554 ·Status: COMPLETED